FindTrial
Sign In

Effect of probiotics on various parameters in diabetic and obese patients

Effect of Probiotics on Neurobehavioral Functions and Body Mass Index in Diabetes -Associated Obesity : A Randomized Controlled Trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/09/073730
Enrollment
60
Registered
2024-09-10
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications

Interventions

Intervention1: Probiotics: 12 weeks one capsule everyday (Lactobacillus and Bifidobacterium) Control Intervention1: Control Group: They will not receive the intervention and will continue with their

Sponsors

UCMS and GTB Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Obese and Diabetic (Type 2 Diabetes Mellitus) patients in the age group between 30-60 years on conventional treatment

Exclusion criteria

Exclusion criteria: 1. Patient with any other acute or chronic medical/surgical/Psychiatric illness 2. Patients already taking probiotic medication 3. Patients taking hypolipidemic drugs

Design outcomes

Primary

MeasureTime frame
1.Change in BMI after 12 weeks 2.Change in serum BDNF levels after 12 weeks Timepoint: 12 weeks—

Secondary

MeasureTime frame
Change in DASS-42 ScoreTimepoint: 12 weeks—

Countries

India

Contacts

Public ContactDr Farah Khaliq

UCMS and GTB Hospital Delhi

farahphysioucms@gmail.com9811907770

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026